中国生物技术、癌症早筛领域前景广阔_OK阅读网
双语新闻
Bilingual News


双语对照阅读
分级系列阅读
智能辅助阅读
在线英语学习
首页 |  双语新闻 |  双语读物 |  双语名著 | 
[英文] [中文] [双语对照] [双语交替]    []        


中国生物技术、癌症早筛领域前景广阔
Nation sees big biz in biotech, early cancer detection

来源:中国日报    2022-06-20 17:17



        New financing events for domestic early cancer screening startups have hit news headlines since the start of the year, despite slides in share prices of many listed biotech companies at home and abroad.尽管国内外许多生物技术上市公司股价下跌,但自今年年初以来,针对国内早癌筛查初创公司的新融资活动占据了新闻头条。
        Shi Lichen, founder of medical consulting firm Beijing Dingchen Consultancy, said cancer is a top killer in China, and boundless opportunities have been presented for early cancer detection industry players because they also target healthy people rather than just cancer patients.医疗咨询公司北京鼎臣咨询创始人史立臣表示,在中国,癌症是头号杀手,早癌筛查行业的从业者有着无限机会,因为他们瞄准的不仅仅是癌症患者,还有健康人群。
        In a new plan to spur the bioeconomy during the 14th Five-Year Plan period (2021-25), the National Development and Reform Commission said it is necessary to promote deep integration of advanced technologies such as genetic testing and disease prevention, and to carry out early screening programs for major diseases, including tumors.国家发展改革委对外发布的《“十四五”生物经济发展规划》提出,要推动基因检测等先进技术与疾病预防深度融合,开展肿瘤等重大疾病早期筛查。
        Zhou Jun, CEO of Berry Oncology, a leading Chinese company in genetic testing and early screening of tumors, said a root cause for investors' sustained enthusiasm for early cancer screening is that although various innovative therapies have been made available in the market in recent years for cancer, once the disease progresses to the middle and late stages, the benefits from drugs will become very limited, while related expenditures at both the individual level and the society level can be huge.贝瑞基因首席执行官周珺表示,投资者对早癌筛查行业投资热情持续高涨的一个根本原因是,尽管近年来市场上有各种创新疗法治疗癌症,但一旦癌症发展到中晚期,药物的作用将变得非常有限,而个人和社会层面的相关支出可能会非常巨大。
        "With the commercial application of next-generation sequencing, we can enable alerts for tumors at a very early stage," he said.他说:“随着下一代测序技术的商业应用,我们可以在肿瘤早期发出警报。”
        "As domestic players started almost at the same time as their foreign counterparts, their overall competence in developing new solutions is somehow of the same level as foreign enterprises," said Shi of Beijing Dingchen Consultancy.史立臣表示:“由于国内企业几乎与国外同行同时起步,他们在开发新解决方案方面的总体能力在某种程度上与外国企业相当。”
        According to a report by Haitong International Securities Group Ltd, China's early cancer detection market will reach more than 162 billion yuan in value within 10 years.根据海通国际证券集团有限公司的一份报告,中国早癌筛查市场估值将在10年内超过1620亿元人民币。
        Zhou, with Berry Oncology, said both central and local Chinese authorities have released guidelines and policies to create better development conditions for the industry. However, more detailed rules for better implementation of those guidelines and policies are expected to help enterprises realize the commercialization of their research and innovations.周珺称,中央和地方政府都发布了指导方针和政策,为早癌筛查行业创造更好的发展条件。更好地细化落实这些指导方针和政策可以帮助企业实现其研究和创新的商业化。
        来源:中国日报编译:董静
        
   返回首页                  

OK阅读网 版权所有(C)2017 | 联系我们